Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News AIkido Pharma SPEX

Healthcare Biotechnology
AIkido Pharma Inc is a United States-based biotechnology company. The company is engaged in the development of small-molecule anti-cancer therapeutics. The company's drug portfolio includes therapies for pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia (ALL).

Recent & Breaking News (NDAQ:SPEX)

Spherix Inc. Announces Closing of the Deal with Hoth Therapeutics

PR Newswire July 3, 2017

15 Biggest Mid-Day Losers For Friday

Benzinga.com  June 30, 2017

22 Stocks Moving In Friday's Pre-Market Session

Benzinga.com  June 30, 2017

12 Biggest Mid-Day Gainers For Thursday

Benzinga.com  June 29, 2017

22 Stocks Moving In Thursday's Pre-Market Session

Benzinga.com  June 29, 2017

Spherix Issues Letter to Shareholders

PR Newswire June 27, 2017

Spherix Inc. Announces Definitive Terms Reached to Acquire Controlling Interest in Hoth Therapeutics, a Biopharmaceutical Company Developing its BioLexa Platform to Treat Skin Illness Such as Eczema.

PR Newswire June 20, 2017

ParkerVision's 80% Gains Have Evaporated

Benzinga.com  March 14, 2017

Your Guide To Patent Play Exposure

Benzinga.com  March 11, 2017

18 Biggest Mid-Day Gainers For Wednesday

Benzinga.com  March 8, 2017

Spherix Announces New Clients in the $100B Online Learning Business

PR Newswire February 21, 2017

Spherix Updates Shareholders

PR Newswire January 23, 2017

New Patent Infringement Lawsuit Filed Against Alcatel-Lucent Under Spherix Collaboration Agreement

PR Newswire December 5, 2016

Spherix Executes Revenue Generating Agreement with LawCash

PR Newswire November 28, 2016

12 Biggest Mid-Day Gainers For Wednesday

Benzinga.com  November 23, 2016

Spherix Signs New Client in the $3.5 Billion Vaporizer Business

PR Newswire November 7, 2016

Spherix Announces Changes to Board of Directors

PR Newswire October 31, 2016

Spherix Launches New Patent Licensing Initiative

PR Newswire October 19, 2016

Spherix Provides Update on Patent Infringement Litigation

PR Newswire October 17, 2016

Spherix Monetization Program Continues to Expand

PR Newswire August 18, 2016